Seipinopathy: a novel endoplasmic reticulum stress-associated disease - PubMed (original) (raw)
Review
. 2009 Jan;132(Pt 1):8-15.
doi: 10.1093/brain/awn216. Epub 2008 Sep 12.
Affiliations
- PMID: 18790819
- DOI: 10.1093/brain/awn216
Review
Seipinopathy: a novel endoplasmic reticulum stress-associated disease
Daisuke Ito et al. Brain. 2009 Jan.
Abstract
The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2 (CGL2), a condition characterized by severe lipoatrophy, insulin resistance, hypertriglyceridaemia and mental retardation. Recently, gain-of-toxic-function mutations (namely, mutations N88S and S90L) in the seipin gene have been identified in autosomal dominant motor neuron diseases such as Silver syndrome/spastic paraplegia 17 (SPG17) (OMIM #270685) and distal hereditary motor neuropathy type V (dHMN-V) (OMIM #182960). Detailed phenotypic analyses have revealed that upper motor neurons, lower motor neurons and peripheral motor axons are variously affected in patients with these mutations. The clinical spectrum for these mutations is broad, encompassing Silver syndrome, some variants of Charcot-Marie-Tooth disease type 2, dHMNV and spastic paraplegia, even within a common pedigree. Therefore, we propose that seipin-related motor neuron diseases can be collectively referred to as 'seipinopathies'. Expression of the seipin protein can be detected in motor neurons in the spinal cord and white matter in the frontal lobe. This is consistent with the distribution of seipinopathies in the upper and lower motor neurons. Recent studies have shown that seipin, an endoplasmic reticulum (ER)-resident membrane protein, is an N-glycosylated protein that is proteolytically cleaved into N- and C-terminal fragments and is polyubiquitinated. Interestingly, the N88S and S90L mutations are in the N-glycosylation motif, and these mutations enhance ubiquitination and degradation of seipin by the ubiquitin-proteasome system (UPS). Furthermore, both mutations appear to result in proteins that are improperly folded, which leads to accumulation of the mutant protein in the ER. We have shown that expression of mutant forms of seipin in cultured cells activates the unfolded protein response (UPR) pathway and induces ER stress-mediated cell death. These findings suggest that seipinopathies are novel conformational diseases and that neurodegeneration in these diseases is tightly associated with ER stress, which has recently been reported to be associated with other neurodegenerative diseases. Further study of the pathological mechanisms of the mutant forms of seipin may lead to important new insights into motor neuron diseases, including other spastic paraplegia diseases and amyotrophic lateral sclerosis.
Similar articles
- N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress.
Yagi T, Ito D, Nihei Y, Ishihara T, Suzuki N. Yagi T, et al. Hum Mol Genet. 2011 Oct 1;20(19):3831-40. doi: 10.1093/hmg/ddr304. Epub 2011 Jul 12. Hum Mol Genet. 2011. PMID: 21750110 - Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases.
Ito D, Suzuki N. Ito D, et al. Ann Neurol. 2007 Mar;61(3):237-50. doi: 10.1002/ana.21070. Ann Neurol. 2007. PMID: 17387721 - Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17.
Ito D, Fujisawa T, Iida H, Suzuki N. Ito D, et al. Neurobiol Dis. 2008 Aug;31(2):266-77. doi: 10.1016/j.nbd.2008.05.004. Epub 2008 May 22. Neurobiol Dis. 2008. PMID: 18585921 - Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE. Hadano S, et al. Neurochem Int. 2007 Jul-Sep;51(2-4):74-84. doi: 10.1016/j.neuint.2007.04.010. Epub 2007 May 4. Neurochem Int. 2007. PMID: 17566607 Review.
Cited by
- Clinical and histopathological study of Charcot-Marie-Tooth neuropathy with a novel S90W mutation in BSCL2.
Choi BO, Park MH, Chung KW, Woo HM, Koo H, Chung HK, Choi KG, Park KD, Lee HJ, Hyun YS, Koo SK. Choi BO, et al. Neurogenetics. 2013 Feb;14(1):35-42. doi: 10.1007/s10048-012-0346-5. Epub 2012 Nov 10. Neurogenetics. 2013. PMID: 23142943 - Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
Nishimoto Y, Ito D, Yagi T, Nihei Y, Tsunoda Y, Suzuki N. Nishimoto Y, et al. J Biol Chem. 2010 Jan 1;285(1):608-19. doi: 10.1074/jbc.M109.022012. Epub 2009 Nov 3. J Biol Chem. 2010. PMID: 19887443 Free PMC article. - Frataxin controls ketone body metabolism through regulation of OXCT1.
Dong YN, Mesaros C, Xu P, Mercado-Ayón E, Halawani S, Ngaba LV, Warren N, Sleiman P, Rodden LN, Schadt KA, Blair IA, Lynch DR. Dong YN, et al. PNAS Nexus. 2022 Jul 26;1(3):pgac142. doi: 10.1093/pnasnexus/pgac142. eCollection 2022 Jul. PNAS Nexus. 2022. PMID: 36016708 Free PMC article. - Charcot-Marie-Tooth disease and intracellular traffic.
Bucci C, Bakke O, Progida C. Bucci C, et al. Prog Neurobiol. 2012 Dec;99(3):191-225. doi: 10.1016/j.pneurobio.2012.03.003. Epub 2012 Mar 22. Prog Neurobiol. 2012. PMID: 22465036 Free PMC article. Review. - Seipin mutation at glycosylation sites activates autophagy in transfected cells via abnormal large lipid droplets generation.
Fan HD, Chen SP, Sun YX, Xu SH, Wu LJ. Fan HD, et al. Acta Pharmacol Sin. 2015 Apr;36(4):497-506. doi: 10.1038/aps.2014.164. Epub 2015 Mar 23. Acta Pharmacol Sin. 2015. PMID: 25832430 Free PMC article.